Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia
- PMID: 20080915
- DOI: 10.3899/jrheum.090781
Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia
Abstract
Objectives: To describe and compare the prevalence of lifetime and current self-reported comorbidity and associated quality of life in 4 rheumatic diseases, and to investigate comorbid conditions in light of the overlap between the index condition and comorbid conditions (CC), and in the context of symptom-type diagnoses.
Methods: We studied comorbidity in 11,704 patients with fibromyalgia (FM), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and noninflammatory rheumatic disorders (NIRD). Patients completed semiannual self-reports relating to 22 present and past illnesses and completed the EuroQol (EQ-5D) utility index.
Results: CC were most common in FM, followed by SLE. FM comorbidity was dominated by depression, mental illness, and symptom-type comorbidity (e.g., gastrointestinal and genitourinary disorders). In SLE, there were substantial increases in hypertension, depression, cataract, fractures, and cardiovascular and cerebrovascular, neurologic, lung, gall bladder and endocrine disorders compared with RA. Any current CC reduced the EQ-5D utility by 0.08 to 0.16 units. The lowest EQ-5D score was noted for current psychiatric illness (0.55) and current depression (0.60).
Conclusion: Four patterns of comorbidity emerged: that associated with aging; that associated with aging but enhanced by the index condition, as in SLE and cardiovascular disease; comorbidity that is part of the symptoms complex of the index condition; and CC that represent lifetime traits or manifestations of the underlying illness. Depression was the most strongly associated correlate of EQ-5D quality of life, and current depression was present in about 15% of patients with RA or NIRD and 34% to 39% of those with SLE and FM.
Similar articles
-
EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.J Rheumatol. 2010 Feb;37(2):296-304. doi: 10.3899/jrheum.090778. Epub 2009 Dec 23. J Rheumatol. 2010. PMID: 20032098
-
Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.J Rheumatol. 2009 Jun;36(6):1209-16. doi: 10.3899/jrheum.081022. Epub 2009 Apr 15. J Rheumatol. 2009. PMID: 19369452
-
Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.J Rheumatol. 2004 Apr;31(4):695-700. J Rheumatol. 2004. PMID: 15088293
-
[Rheumatic diseases as risk factors for cardiovascular disease].Ned Tijdschr Geneeskd. 2006 Sep 2;150(35):1921-4. Ned Tijdschr Geneeskd. 2006. PMID: 16999275 Review. Dutch.
-
The interface of pain and mood disturbances in the rheumatic diseases.Semin Arthritis Rheum. 2010 Aug;40(1):15-31. doi: 10.1016/j.semarthrit.2008.11.005. Epub 2009 Feb 13. Semin Arthritis Rheum. 2010. PMID: 19217649 Review.
Cited by
-
Predictors of longterm changes in body mass index in rheumatoid arthritis.J Rheumatol. 2015 Jun;42(6):920-7. doi: 10.3899/jrheum.141363. Epub 2015 Apr 1. J Rheumatol. 2015. PMID: 25834210 Free PMC article.
-
COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour.Mod Rheumatol. 2023 Jul 4;33(4):777-785. doi: 10.1093/mr/roac069. Mod Rheumatol. 2023. PMID: 35860843 Free PMC article.
-
Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan.Clin Rheumatol. 2017 Jan;36(1):133-142. doi: 10.1007/s10067-016-3471-y. Epub 2016 Nov 12. Clin Rheumatol. 2017. PMID: 27837342
-
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study.RMD Open. 2023 Dec 20;9(4):e003714. doi: 10.1136/rmdopen-2023-003714. RMD Open. 2023. PMID: 38123483 Free PMC article.
-
Comparison of the Charlson Comorbidity Index derived from self-report and medical record review in Asian patients with rheumatic diseases.Rheumatol Int. 2015 Dec;35(12):2005-11. doi: 10.1007/s00296-015-3296-z. Epub 2015 Jun 10. Rheumatol Int. 2015. PMID: 26059942
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous